摘要
随着国内外研究进展,在中华医学会第十七次全国病毒性肝炎及肝病学术会议上发布了2015版《中国慢性乙型肝炎防治指南》,概念明确、内容细化,总结了流行病学、发病机制、肝纤维化非侵袭性诊断等方面的新进展,突出抗病毒治疗的重要性,包括特殊人群抗病毒均给出详实推荐意见,同时指出未来乙型肝炎防治的方向。总之,新版指南的颁布必将有助于进一步规范与提高我国乙型肝炎防治水平。
As the researches home and abroad progress, the 2015 edition of Chinese Clinical Practice Guidelines ： Prevention and Management of Chronic Hepatitis B was published in the 17th national conference on viral hepatitis and liver disease of Chinese Medical Association. With clear concept, the content refinement, summarization of the epidemiology, pathogenesis, noninvasive diagnosis of liver fibrosis, new guidelines highlight the importance of antiviral therapy and give detailed recommendations including in special populations, as well as point out the direction prevention and management of the chronic hepatitis B in the future. In a word, the publication of the new guidelines will help further standardize and improve the level of hepatitis B prevention and management in China.
出处
《临床荟萃》
CAS
2016年第7期701-704,共4页
Clinical Focus
关键词
肝炎
乙型
慢性
抗病毒药
指南
hepatitis B, chronic
antiviral agents
guidelines
